Imugene Stock Annual Yield
IMU Stock | 0.04 0 2.63% |
Imugene fundamentals help investors to digest information that contributes to Imugene's financial success or failures. It also enables traders to predict the movement of Imugene Stock. The fundamental analysis module provides a way to measure Imugene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imugene stock.
Imugene | Annual Yield |
Imugene Company Annual Yield Analysis
Imugene's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Imugene has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Imugene Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imugene's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Imugene could also be used in its relative valuation, which is a method of valuing Imugene by comparing valuation metrics of similar companies.Imugene is currently under evaluation in annual yield category among its peers.
Imugene Fundamentals
Return On Equity | -0.97 | ||||
Return On Asset | -0.51 | ||||
Operating Margin | 22.86 % | ||||
Current Valuation | 188.42 M | ||||
Shares Outstanding | 7.57 B | ||||
Shares Owned By Insiders | 14.38 % | ||||
Shares Owned By Institutions | 6.64 % | ||||
Price To Book | 2.37 X | ||||
Price To Sales | 54.81 X | ||||
Revenue | 4.97 M | ||||
Gross Profit | 11.78 M | ||||
EBITDA | (147.98 M) | ||||
Net Income | (149.68 M) | ||||
Cash And Equivalents | 49.54 M | ||||
Total Debt | 1.55 M | ||||
Book Value Per Share | 0.02 X | ||||
Cash Flow From Operations | (97.32 M) | ||||
Earnings Per Share | (0.02) X | ||||
Target Price | 0.3 | ||||
Beta | 3.34 | ||||
Market Capitalization | 272.41 M | ||||
Total Asset | 151.4 M | ||||
Retained Earnings | (289.83 M) | ||||
Working Capital | 83.74 M | ||||
Net Asset | 151.4 M |
About Imugene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Imugene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imugene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imugene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.